NasdaqGS:KNSABiotechs
Is It Too Late To Consider Kiniksa Pharmaceuticals (KNSA) After Its 91% One-Year Surge?
If you are wondering whether Kiniksa Pharmaceuticals International at around US$52.99 is genuinely good value or just riding sentiment, the starting point is to look closely at what the current price implies.
The stock shows recent returns of 23.1% over 7 days, 10.1% over 30 days, 26.2% year to date and 91.0% over the past year, which naturally raises questions about how much of the story is already reflected in the share price.
Recent news around the company has focused on its position...